US Stock MarketDetailed Quotes

KZIA Kazia Therapeutics

Watchlist
  • 5.520
  • +0.120+2.22%
Close Nov 1 16:00 ET
  • 5.550
  • +0.030+0.54%
Post 20:01 ET
18.37MMarket Cap-1502P/E (TTM)

Kazia Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Kazia Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: AUD

Actual
Estimate
Date Period Revenue/Estimate Earnings Call
-- 2023/H2 22.970K / 11.500K --
-- 2023/H1 140.000 / 1.100K --
-- 2022/H2 110.000 / 338.670K --
-- 2022/H1 26.950K / 0.000 --
-- 2021/H2 15.180M / 18.700M --
DatePeriodRevenue/EstimateEarnings Call
--2023/H222.970K / 11.500K--
--2023/H1140.000 / 1.100K--
--2022/H2110.000 / 338.670K--
--2022/H126.950K / 0.000--
--2021/H215.180M / 18.700M--

Unlock Free Earnings Estimates

Kazia Therapeutics Earnings Reports

  • Kazia Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

    Apr 20 04:31

  • Kazia Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

    Mar 27 20:29

  • Kazia Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

    Dec 6, 2023 21:31

  • Kazia Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

    Nov 30, 2023 05:02

    • Read more

    Analysis

    Analyst Rating

    No Data

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data